Basic info
Industry
biotechnology research
Sectors
Immuno oncology
Biotechnology
Autoantibodies
Lung cancer
Pulmonary nodules
Early cancer detection
Systemic Lupus
Systemic Sclerosis
Lung cancer detection
Commercial
COVID-19
Autoimmune Disease
Infectious disease
Immunotherapy
Bioinformatics
Companion diagnostics
Cancer
Date founded
2006
Funding rounds raised
Total raised
$119K
from 3 investors over 3 rounds
O
Oncimmune Limited & EarlyCDT-Lung raised $119K on February 1, 2017
Investors: SBRI Healthcare
O
Oncimmune Limited & EarlyCDT-Lung raised undisclosed on December 31, 2014
Investors: Claret Capital Partners
O
Oncimmune Limited & EarlyCDT-Lung raised undisclosed on October 1, 2007
Investors: Balderton Capital